' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | NUEDEXTA is the first and only FDA-approved treatment for Pseudobulbar Affect (PBA). Available in 20 mg/10 mg oral capsules. See safety and prescribing info. |
h1 tags | Have you screened your patients for PBA? |
h2 tags | Eyebrow Stay Informed Footer Nav - Col 1 Footer Nav - Col 2 Footer You are now leaving NUEDEXTAHCP.com. This link may take you to an external site not controlled by Otsuka America Pharmaceutical, Inc. The contents of this site are intended for US Healthcare Professionals. Please certify that you are a healthcare professional by clicking the appropriate link below. REQUEST A SAMPLE Thank you! Save on 90-day prescriptions: NOW INCLUDING HIGH DEDUCTIBLE PLANS |
Site Speed | 0.40778613090515 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| nuedextahcp.com | HINFO | IN | 3789 |